Profarma Distribuidora de Produtos Farmaceuticos SA
BOVESPA:PFRM3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBIT
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBIT returns to its 3-Year Average (4.8), the stock would be worth R$7.63 (0% downside from current price).
| Scenario | EV/EBIT Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 4.8 | R$7.65 |
0%
|
| 3-Year Average | 4.8 | R$7.63 |
0%
|
| 5-Year Average | 4.8 | R$7.71 |
+1%
|
| Industry Average | 8.2 | R$13.16 |
+72%
|
| Country Average | 8.3 | R$13.24 |
+73%
|
Forward EV/EBIT
Today’s price vs future ebit
Peer Comparison
| Market Cap | EV/EBIT | P/E | ||||
|---|---|---|---|---|---|---|
| BR |
|
Profarma Distribuidora de Produtos Farmaceuticos SA
BOVESPA:PFRM3
|
938m BRL | 4.8 | 7.9 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
101.9B USD | 18.6 | 23.5 | |
| US |
|
Cencora Inc
NYSE:COR
|
59.9B USD | 16.6 | 36.9 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
59.4B USD | 16.4 | 36.6 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
47.2B USD | 17.9 | 28.4 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
32.1B AUD | 26.2 | 35.3 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
62.9B CNY | 8.6 | 11 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
9B USD | 15.6 | 22.6 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
59.8B CNY | 12.5 | 16.2 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 61.9 | 89.6 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
61B HKD | 0.7 | 7.6 |
Market Distribution
| Min | 0.4 |
| 30th Percentile | 6.8 |
| Median | 8.3 |
| 70th Percentile | 11.3 |
| Max | 288 |
Other Multiples
Profarma Distribuidora de Produtos Farmaceuticos SA
Glance View
Profarma Distribuidora de Produtos Farmaceuticos SA provides wholesale operations to pharmaceutical retailers, with the sale of medicines and health and beauty products. The company is headquartered in Rio De Janeiro, Rio De Janeiro. The company went IPO on 2006-10-26. The firm's activities are divided into two segments: Pharmaceutical Distribution and Retail. The Pharmaceutical Distribution division is responsible for the wholesale of medicines and personal care and beauty products to pharmaceutical retailers. The Retail division focuses on the management of a pharmacies network under a number of brand names, such as Drogasmil and Tamoio. Its products range includes prescription drugs, over-the-counter (OTC) generics, personal hygiene articles and cosmetics, vaccines, dermatological products and hospital pharmaceuticals, among others. The firm's subsidiaries include Farmadacta Informatica Ltda, Promovendas Representacoes Ltda, Interagile Propaganda e Promocoes Ltda and Locafarma Solucoes de Transportes e Logistica Ltda, among others.
